Internal ribosome entry site of bFGF is the target of thalidomide for IMiDs development in multiple myeloma

Although new analogues of immunomodulatory drugs (IMiDs) are being developed for MM, the molecular mechanism of these drugs remains unclear. In the current study, we used MM cell lines as a model to investigate the molecular mechanism of thalidomide and to compare its potency with IMiDs such as poma...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lien, I-Chia, Horng, Lin-Yea, Hsu, Pei-Lun, Wu, Chia-Ling, Sung, Hui-Ching, Wu, Rong-Tsun
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2014
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4091528/
https://ncbi.nlm.nih.gov/pubmed/25053990
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi